Diagnostic and Guided Interventional Cardiology Products Market

  • ID: 4421574
  • Report
  • 174 pages
  • MedDeviceTracker
1 of 3
The global market for diagnostic and guided interventional cardiology products is being driven by the increasing burden of cardiovascular disease (CVD). CVD is the leading cause of death globally, responsible for over 17 million deaths annually. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global diagnostic and guided interventional cardiology products market, which includes transcatheter angiography, guidewire-based intravascular stenosis assessment, intracardiac echocardiography (ICE), intravascular ultrasound (IVUS), optical coherence tomography (OCT), and robotic-assisted surgical systems.

Global product sales are projected to expand at a compound annual growth rate (CAGR) of 6.4% during 2016-21, increasing from approximately $3,491.3m in 2016 to an estimated $4,761.4m in 2021. Countries/regions covered by this report include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of the World segment (which combines estimated sales data for all other countries).

This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for diagnostic and guided interventional cardiology products.

Topics Covered Include:
  • An overview of diagnostic and guided interventional cardiology devices, including transcatheter angiography, fraction flow reserve, intracardiac echocardiography (ICE), intravascular ultrasound, optical coherence tomography (OCT), as well as robotic-assisted surgical systems.
  • Global and country/region-specific market forecasts, including forecasts by product segment.
  • Competitive analyses by product segment.
  • Discussion of key drivers and limiters impacting the major product segments.
  • Country and region-specific insights that are influencing the utilization of diagnostic and guided interventional cardiology devices.
  • A review of emerging technologies which could impact sales of existing devices.
Report Highlights:
  • Diagnostic interventional cardiology products are being utilized less frequently in the preoperative work-up of patients with suspected cardiovascular disease. These technologies are primarily utilized to guide minimally invasive therapies (eg stenting).
  • Angiography devices, including cardiac X-ray systems and transcatheter devices, accounted for 59% of total product sales in 2016. Sales of ICE and OCT systems are expected to experience the strongest growth throughout the forecast period (2016-21).
  • The market for diagnostic and guided interventional cardiology devices is anticipated to experience moderate growth during the forecast period, increasing to an estimated $4.8bn by 2021.
  • The increasing burden of cardiovascular diseases (CVDs) and the growing elderly demographic, a high risk demographic for the development of CVDs, are the main factors driving growth in product sales.
  • The US market for diagnostic and guided interventional cardiology devices accounted for approximately 35% of all sales, followed by the five major European markets (France, Germany, Italy, Spain, and the UK). The strongest growth in biopsy product sales is expected to occur in the Rest of the World segment, which is being driven by demand for more sophisticated healthcare services in emerging markets.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
Executive Summary
i. Cardiovascular diseases overview
ii. Global diagnostic and guided interventional cardiology products market
a. Selected market drivers and limiters
b. Device segment insights
c. Technology trends
iii. Methodology

1. Cardiovascular Diseases Overview
1.1 Acute coronary syndrome
1.1.1 Atherosclerosis
1.1.2 Angina pectoris
1.1.3 Myocardial infarction
1.2 Hypertension
1.3 Cardiomyopathy
1.4 Congenital heart defects
1.5 Heart failure
1.6 Peripheral vascular disease
1.7 Cerebrovascular disease
1.8 Bibliography

2. Diagnostic and Guided Interventional Cardiology Products
2.1 Angiography
2.1.1 Angiography catheters
2.1.2 Angiography guidewires
2.1.3 Cardiovascular X-ray systems
2.2 Fractional flow reserve
2.2.1 Fractional flow reserve products
2.3 Intracardiac echocardiography
2.3.1 Intracardiac echocardiography products
2.4 Intravascular ultrasound
2.4.1 Products
2.5 Optical coherence tomography
2.5.1 Products
2.6 Robotic-assisted systems
2.6.1 Products
2.6.2 Emerging technology
2.7 Bibliography

3. Diagnostic and Guided Interventional Cardiology Products Market
3.1 Global competitors
3.1.1 Angiography systems competitive analysis
3.1.2 Fractional flow reserve systems competitive analysis
3.1.3 Intracardiac echocardiography systems competitive analysis
3.1.4 Intravascular ultrasound systems competitive analysis
3.1.5 Optical coherence tomography systems competitive analysis
3.1.6 Robotic-assisted surgical systems competitive analysis
3.2 Market forecast: US
3.2.1 Angiography systems market
3.2.2 Fractional flow reservice systems market
3.2.3 Intracardiac echocardiography systems market
3.2.4 Intravascular ultrasound systems market
3.2.5 Optical coherence tomography systems market
3.2.6 Robotic-assisted surgical systems market
3.3 Market forecast: five major EU markets
3.3.1 Angiography systems market
3.3.2 Fractional flow reserve systems market
3.3.3 Intracardiac echocardiography systems market
3.3.4 Intravascular ultrasound systems market
3.3.5 Optical coherence tomography systems market
3.3.6 Robotic-assisted surgical systems market
3.4 Market forecast: Japan
3.4.1 Angiography systems market
3.4.2 Fractional flow reserve systems market
3.4.3 Intracardiac echocardiography systems market
3.4.4 Intravascular ultrasound systems market
3.4.5 Optical coherence tomography systems market
3.4.6 Robotic-assisted surgical systems market
3.5 Market forecast: RoW
3.5.1 Angiography systems market
3.5.2 Fractional flow reserve systems market
3.5.3 Intracardiac echocardiography systems market
3.5.4 Intravascular ultrasound systems market
3.5.5 Optical coherence tomography systems market
3.5.6 Robotic-assisted surgical systems market
3.6 Bibliography

List of Exhibits
Exhibit ES-1: Diagnostic and guided interventional cardiology products, global market forecast, 2016-21
Exhibit ES-2: Global diagnostic and guided interventional cardiology products market, share by country/region, 2016
Exhibit 1-1: Estimated mortality due to ischemic heart disease and cerebrovascular disease, select countries
Exhibit 1-2: Top 10 countries with the highest CVD death rates
Exhibit 1-3: Estimated incidence rates for acute coronary syndrome, select countries
Exhibit 1-4: Age-standardized incidence (000s) of angina pectoris, select regions
Exhibit 1-5: Clinical classification of acute myocardial infarction
Exhibit 1-6: Age-standardized incidence (000s) of acute myocardial infarction, select regions
Exhibit 1-7: Estimated incidence rates for myocardial infarction, select countries
Exhibit 1-8: Estimated prevalence of hypertension, select countries
Exhibit 1-9: Mortality attributable to hypertensive diseases, select countries
Exhibit 1-10: Age-standardized prevalence of heart failure, select regions
Exhibit 1-11: Estimated prevalence of chronic heart failure, select countries
Exhibit 1-12: Estimated incidence rates for stroke, select countries
Exhibit 1-13: Estimated prevalence of stroke, select countries
Exhibit 2-1: Advantages and disadvantages of conventional angiography
Exhibit 2-2: Select images of angiography catheters
Exhibit 2-3: Selected angiography catheters and manufacturers
Exhibit 2-4: Select images of angiography guidewires
Exhibit 2-5: Selected angiography guidewires and manufacturers
Exhibit 2-6: Select images of cardiac X-ray systems
Exhibit 2-7: Selected cardiac X-ray systems and manufacturers
Exhibit 2-8: Select images of FFR systems
Exhibit 2-9: Selected fractional flow reserve systems and manufacturers
Exhibit 2-10: Advantages and disadvantages of intracardiac echocardiography
Exhibit 2-11: Select images of intracardiac echocardiography systems
Exhibit 2-12: Selected intracardiac echocardiography systems and manufacturers
Exhibit 2-13: Advantages and disadvantages of IVUS
Exhibit 2-14: Select images of intravascular ultrasound systems
Exhibit 2-15: Selected intravascular ultrasound systems and manufacturers
Exhibit 2-16: Advantages and disadvantages of OCT
Exhibit 2-17: Select images of optical coherence tomography systems
Exhibit 2-18: Selected optical coherence tomography systems and manufacturers
Exhibit 2-19: Advantages and disadvantages of robotic-assisted systems
Exhibit 2-20: Select images of robotic-assisted systems
Exhibit 2-21: Selected robotic-assisted systems and manufacturers
Exhibit 3-1: Diagnostic and guided interventional cardiology products, global market forecast ($m), 2016-21
Exhibit 3-2: Diagnostic and guided interventional cardiology product sales by product segment, combined market forecast ($m), 2016-21
Exhibit 3-3: Average sale price of selected diagnostic and guided interventional cardiology products
Exhibit 3-4: Global diagnostic and guided interventional cardiology products market, share by country/region, 2016
Exhibit 3-5: Global diagnostic and guided interventional cardiology product sales by country/region, combined market forecast ($m), 2016-21
Exhibit 3-6: Global angiography devices market, share by supplier, 2016
Exhibit 3-7: Global fractional flow reserve systems market, share by supplier, 2016
Exhibit 3-8: Global intracardiac echocardiography systems market, share by supplier, 2016
Exhibit 3-9: Global intravascular ultrasound systems market, share by supplier, 2016
Exhibit 3-10: Global optical coherence tomography systems market, share by supplier, 2016
Exhibit 3-11: Global robotic-assisted surgical systems market, share by supplier, 2016
Exhibit 3-12: US Diagnostic and guided interventional cardiology product sales by product segment, combined market forecast ($m), 2016-21
Exhibit 3-13: US angiography systems, market forecast ($m), 2016-21
Exhibit 3-14: US angiography devices market, share by supplier, 2016
Exhibit 3-15: US fractional flow reserve systems, market forecast ($m), 2016-21
Exhibit 3-16: US fractional flow reserve systems market, share by supplier, 2016
Exhibit 3-17: US intracardiac echocardiography systems, market forecast ($m), 2016-21
Exhibit 3-18: US intracardiac echocardiography systems market, share by supplier, 2016
Exhibit 3-19: US intravascular ultrasound systems, market forecast ($m), 2016-21
Exhibit 3-20: US intravascular ultrasound systems market, share by supplier, 2016
Exhibit 3-21: US optical coherence tomography systems, market forecast ($m), 2016-21
Exhibit 3-22: US robotic-assisted surgical systems, market forecast ($m), 2016-21
Exhibit 3-23: US robotic-assisted surgical systems market, share by supplier, 2016
Exhibit 3-24: 5EU Diagnostic and guided interventional cardiology product sales by product segment, combined market forecast ($m), 2016-21
Exhibit 3-25: 5EU angiography systems, market forecast ($m), 2016-21
Exhibit 3-26: 5EU angiography devices market, share by supplier, 2016
Exhibit 3-27: 5EU fractional flow reserve systems, market forecast ($m), 2016-21
Exhibit 3-28: 5EU fractional flow reserve systems market, share by supplier, 2016
Exhibit 3-29: 5EU intracardiac echocardiography systems, market forecast ($m), 2016-21
Exhibit 3-30: 5EU intracardiac echocardiography systems market, share by supplier, 2016
Exhibit 3-31: 5EU intravascular ultrasound systems, market forecast ($m), 2016-21
Exhibit 3-32: 5EU intravascular ultrasound systems market, share by supplier, 2016
Exhibit 3-33: 5EU optical coherence tomography systems, market forecast ($m), 2016-21
Exhibit 3-34: 5EU optical coherence tomography systems market, share by supplier, 2016
Exhibit 3-35: 5EU robotic-assisted surgical systems, market forecast ($m), 2016-21
Exhibit 3-36: 5EU robotic-assisted surgical systems market, share by supplier, 2016
Exhibit 3-37: Japan Diagnostic and guided interventional cardiology product sales by product segment, combined market forecast ($m), 2016-21
Exhibit 3-38: Japan angiography systems, market forecast ($m), 2016-21
Exhibit 3-39: Japan angiography devices market, share by supplier, 2016
Exhibit 3-40: Japan fractional flow reserve systems, market orecast ($m), 2016-21
Exhibit 3-41: Japan fractional flow reserve systems market, share by supplier, 2016
Exhibit 3-42: Japan intracardiac echocardiography systems, market forecast ($m), 2016-21
Exhibit 3-43: Japan intracardiac echocardiography systems market, share by supplier, 2016
Exhibit 3-44: Japan intravascular ultrasound systems, market forecast ($m), 2016-21
Exhibit 3-45: Japan intravascular ultrasound systems market, share by supplier, 2016
Exhibit 3-46: Japan optical coherence tomography systems, market forecast ($m), 2016-21
Exhibit 3-47: Japan optical coherence tomography systems market, share by supplier, 2016
Exhibit 3-48: Japan robotic-assisted surgical systems, market forecast ($m), 2016-21
Exhibit 3-49: Japan robotic-assisted surgical systems market, share by supplier, 2016
Exhibit 3-50: RoW diagnostic and guided interventional cardiology product sales by product segment, combined market forecast ($m), 2016-21
Exhibit 3-51: RoW angiography systems, market forecast ($m), 2016-21
Exhibit 3-52: RoW angiography devices market, share by supplier, 2016
Exhibit 3-53: RoW fractional flow reserve systems, market forecast ($m), 2016-21
Exhibit 3-54: RoW fractional flow reserve systems market, share by supplier, 2016
Exhibit 3-55: RoW intracardiac echocardiography systems, market forecast ($m), 2016-21
Exhibit 3-56: RoW intracardiac echocardiography systems market, share by supplier, 2016
Exhibit 3-57: RoW intravascular ultrasound systems, market forecast ($m), 2016-21
Exhibit 3-58: RoW intravascular ultrasound systems market, share by supplier, 2016
Exhibit 3-59: RoW optical coherence tomography systems, market forecast ($m), 2016-21
Exhibit 3-60: RoW optical coherence tomography systems market, share by supplier, 2016
Exhibit 3-61: RoW robotic-assisted surgical systems, market forecast ($m), 2016-21
Exhibit 3-62: RoW robotic-assisted surgical systems market, share by supplier, 2016
  • Appendix: Company Listing
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll